The University of Chicago Header Logo

Connection

Andrzej Jakubowiak to Signaling Lymphocytic Activation Molecule Family

This is a "connection" page, showing publications Andrzej Jakubowiak has written about Signaling Lymphocytic Activation Molecule Family.
  1. First-in-Human Phase I Study of ABBV-838, an Antibody-Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma. Clin Cancer Res. 2020 05 15; 26(10):2308-2317.
    View in: PubMed
    Score: 0.185
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.